Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study

American Journal of Clinical Nutrition

Volumn 86, Issue 3, 2007, Pages 672-681

  Key, Timothy J ^a   Appleby, Paul N ^a   Allen, Naomi E ^a   Travis, Ruth C ^a   Roddam, Andrew W ^a   Jenab, Mazda ^b   Egevad, Lars ^b   Tjønneland, Anne ^c   Johnsen, Nina F ^c   Overvad, Kim ^d   Linseisen, Jakob ^e   Rohrmann, Sabine ^e   Boeing, Heiner ^f   Pischon, Tobias ^f   Psaltopoulou, Theodora ^g   Trichopoulou, Antonia ^g   Trichopoulos, Dimitrios ^g   Palli, Domenico ^h   Vineis, Paolo ^i,j   Tumino, Rosario ^k   Berrino, Franco ^l   Kiemeney, Lambertus ^m   Bueno de Mesquita, H Bas ⁿ   Quirós, J Ramón ^o   González, Carlos A ^p   Martinez, Carmen ^q   Larrañaga, Nerea ^r   Chirlaque, María Dolores ^s   Ardanaz, Eva ^t   Stattin, Pär ^u   Hallmans, Göran ^u   Khaw, Kay Tee ^v   Bingham, Sheila ^v   Slimani, Nadia ^b   Ferrari, Pietro ^b   Rinaldi, Sabina ^b   Riboli, Elio ^j   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^g UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^h Scientific Institute of Tuscany   (Italy)

ⁱ UNIVERSITY OF TURIN   (Italy)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k Azienda Ospedaliera   (Italy)

^l NATIONAL CANCER INSTITUTE   (Italy)

^m RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^o Public Health and Health Planning Directorate   (Spain)

^p CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^q ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^r Public Health Department of Gipuzkoa   (Spain)

^s DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^t INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^u UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^v UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

Carotenoids; Lycopene; Nested case control study; Prostate cancer; Retinol; Tocopherols

Indexed keywords

ALCOHOL; ALPHA CAROTENE; ALPHA TOCOPHEROL; BETA CAROTENE; BETA CRYPTOXANTHIN; CANTHAXANTHIN; CAROTENOID; GAMMA TOCOPHEROL; LYCOPENE; RETINOL DERIVATIVE; TOCOPHEROL DERIVATIVE; TRACE ELEMENT; XANTHOPHYLL; ZEAXANTHIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIET; EDUCATION; EUROPE; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MARRIAGE; NUTRITION; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; PROSTATE CANCER; RISK FACTOR; SMOKING; VITAMIN BLOOD LEVEL;

EID: 34548707081     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/86.3.672     Document Type: Article

References (41)

1. International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention. Carotenoids. Vol 2. Lyon, France: International Agency for Research on Cancer, 1998.
2. Chan JM, Gann PH, Giovannucci EL. Role of diet in prostate cancer development and progression. J Clin Oncol 2005;23:8152-60.
3. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24.
4. Al-Delaimy WK, Slimani N, Ferrari P et al. Plasma carotenoids as biomarkers of intake of fruits and vegetables: ecological-level correlations in the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Clin Nutr 2005;59:1397-408.
5. Key TJ, Allen N, Appleby P, et al. Fruits and vegetables and prostate cancer: no association among 1104 cases in a prospective study of 130 544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2004;109:119-24.
6. Krinsky NI, Johnson EJ. Carotenoid actions and their relation to health and disease. Mol Aspects Med 2005;26:459-516.
7. O'Neill ME, Carroll Y, Corridan B, et al. A European carotenoid database to assess carotenoid intakes and its use in a five-country comparative study. Br J Nutr 2001;85:499-507.
8. Jenab M, Ferrari P, Mazuir M, et al. Variations in lycopene blood levels and tomato consumption across European countries based on the European Prospective Investigation into Cancer and Nutrition (EPIC) study. J Nutr 2005;135(suppl):2032S-6S.
9. Schlatterer J, Breithaupt DE. Xanthophylls in commercial egg yolks: quantification and identification by HPLC and LC-(APCI)MS using a C30 phase. J Agric Food Chem 2006;54:2267-73.
10. McKevith B. Is salmon salmon pink? The use of canthaxanthin in animal feeds. Nutr Bull 2003;28:243-5.
11. Ford ES, Schleicher RL, Mokdad AH, Ajani UA, Liu S. Distribution of serum concentrations of α-tocopherol and γ-tocopherol in the US population. Am J Clin Nutr 2006;84:375-83.
12. Steghens JP, van Kappel AL, Riboli E, Collombel C. Simultaneous measurement of seven carotenoids, retinol and alpha-tocopherol in serum by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1997;694:71-81.
13. Jenab M, Riboli E, Ferrari P, et al. Plasma and dietary carotenoid, retinol and tocopherol levels and the risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 2006;95:406-15.
14. Hsing AW, Comstock GW, Abbey H, Polk BF. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst 1990;82:941-6.
15. Reichman ME, Hayes RB, Ziegler RG, et al. Serum vitamin A and subsequent development of prostate cancer in the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Cancer Res 1990;50:2311-5.
16. Nomura AM, Stemmermann GN, Lee J, Craft NE. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 1997;6:487-91.
17. Hartman TJ, Albanes D, Pietinen P, et al. The association between baseline vitamin E, selenium, and prostate cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Cancer Epidemiol Biomarkers Prev 1998;7:335-40.
18. Eichholzer M, Stahelin HB, Ludin E, Bernasconi F. Smoking, plasma vitamins C, E, retinol, and carotene, and fatal prostate cancer: seventeen-year follow-up of the prospective Basel study. Prostate 1999;38:189-98.
19. Gann PH, Ma J, Giovannucci E, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 1999;59:1225-30.
20. Goodman GE, Schaffer S, Omenn GS, Chen C, King I. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev 2003;12:518-26.
21. Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol 2003;157:335-44.
22. Wu K, Erdman JW Jr, Schwartz SJ, et al. Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2004;13:260-9.
23. Weinstein SJ, Wright ME, Pietinen P, et al. Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study. J Natl Cancer Inst 2005;97:396-9.
24. Melia J, Moss S, Johns L; Contributors in the participating laboratories. Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study. BJU Int 2004;94:51-6.
25. Otto SJ, van der Cruijsen IW, Liem MK, et al. Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. Int J Cancer 2003;105:394-9.
26. Paez A, Lujan M, Llanes L, Romero I, de la Cal MA, Miravalles E, Berenguer A. PSA-use in a Spanish industrial area. Eur Urol 2002;41:162-6.
27. D'Ambrosio G, Samani F, Cancian M, De Mola C. Practice of opportunistic prostate-specific antigen screening in Italy: data from the Health Search database. Eur J Cancer Prev 2004;13:383-6.
28. Etzioni R, Berry KM, Legler JM, Shaw P. Prostate-specific antigen testing in black and white men: an analysis of Medicare claims from 1991-1998. Urology 2002;59:251-5.
29. van Kappel AL, Steghens JP, Zeleniuch-Jacquotte A, Chajes V, Toniolo P, Riboli E. Serum carotenoids as biomarkers of fruit and vegetable consumption in the New York Women's Health Study. Public Health Nutr 2001;4:829-35.
30. Comstock GW, Burke AE, Hoffman SC, Norkus EP, Gross M, Helzlsouer KJ. The repeatability of serum carotenoid, retinoid, and tocopherol concentrations in specimens of blood collected 15 years apart. Cancer Epidemiol Biomarkers Prev 2001;10:65-8.
31. Kirsh VA, Mayne ST, Peters U, et al. A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006;15:92-8.
32. Kirsh VA, Hayes RB, Mayne ST, et al. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst 2006;98:245-54.
33. Virtamo J, Pietinen P, Huttunen JK, et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 2003;290:476-85.
34. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-49.
35. Cook NR, Stampfer MJ, Ma J, et al. Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer 1999;86:1783-92.
36. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
37. Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005;293:1338-47.
38. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:23-33.
39. Heber D, Lu QY. Overview of mechanisms of action of lycopene. Exp Biol Med (Maywood) 2002;227:920-3.
40. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349:215-24.
41. Siler U, Barella L, Spitzer V, et al. Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. FASEB J 2004;18:1019-21.